Ethics
38 blogs about the topic
Association-led compliance conferences: that’s where real change happens
As AdvaMed and Eucomed prepare for our next Global MedTech Compliance Conference May 20-22, 2014 in Barcelona, Spain, I reflect on the remarkable policy outcomes attributed to our past conference discussions. Our MedTech association-led compliance conferences offer a platform—not available in a commercial compliance conference—to spur discussion and best practices exchange among compliance leaders on […]
Compliance fragments – the ever-shifting landscape
In 2008 Eucomed published its revised Code of Ethical Business Practice. We’re six years on now and we’re thinking about writing a new one. Why? Because so much has changed in the world of medtech compliance.
Are human genes patentable in Europe and the US?
In June, the US Supreme Court issued its opinion in the Myriad case (Association for Molecular Pathology v. Myriad Genetics Inc.). The Supreme Court had been asked a seemingly simple question: “Are human genes patentable?”, and concluded that naturally occurring gene sequences are no longer patentable in the US. In Europe, isolated gene sequences are still patentable, under certain conditions. However, the differences between the two legal regimes are not as stark as might initially appear, and the practical effect for the diagnostics industry is complex.
Posted on 16.07.2012
Transparency in the HCP-Industry relationship: supporting industry efforts with an effective legal framework
For the medical technology industry, collaboration with healthcare professionals (HCPs) is an absolute must. HCPs are prime users of new technology and play an instrumental role in the successful diffusion of innovative medical devices throughout Europe. In fact, HCPs often bring the ideas to the table that lead to the development of new devices and inspire continuous incremental improvements to existing technology.
Posted on 26.04.2012
Ethics and compliance in the MedTech industry: on the agenda in Stockholm
For medtech companies, interacting with Healthcare Professionals (HCPs) is a fact of life. HCPs are an integral part of the R&D process and a source of innovation and creativity throughout the development of medical devices. HCPs are also the prime users of technologies and play an instrumental role in the successful adoption of innovative medical devices in Europe, the US and beyond. With the adoption of new anti-bribery laws in a number of countries, increasing enforcement and new pressures from investors and the general public, the International Medical Device Industry Compliance Conference on 9-11 May in Stockholm, is well-timed to provide a platform for stakeholders to discuss these mounting challenges.
Why patient safety and HTA are important – for us all
Too often we, as stakeholders in health, forget about whom we are talking when we say “patients.” We talk as if the patient is somewhere far away from our discussions rather than the person with whom, about whom and for whom we are having those discussions. In reality, we are all patients – for some it’s just once a year and for others it’s every day of the year. But it’s important to remember that health policy should, theoretically, benefit all of us when it is our turn to receive healthcare – no matter what that care is.
Posted on 27.01.2012
Launch of first conference vetting system: getting closer…
In October last year, Eucomed published a press release to introduce to its broader membership and stakeholders the launch of a new “Conference vetting system” in 2012. Aimed to simplify decision-making for Eucomed members by providing clear approvals on sponsorship of events, this unique initiative in our industry has already interested the media, including an article in the Financial Times.
Posted on 04.05.2011
How we in the U.S. see global compliance challenges for MedTech companies
AdvaMed and Eucomed are co-organizing the upcoming International Medical Device Industry Compliance Conference, taking place on 18-20 May in London. Both AdvaMed and Eucomed worked closely with our member companies to identify the hottest issues in medical device industry compliance today to shape a truly global, industry specific event. We also worked together to invite accomplished discussion leaders and moderators, and panel participants representing North American and European perspectives and experiences.
Posted on 01.10.2010
Adam Smith, corruption and biases
The 7th European Healthcare Fraud & Corruption Network conference took place in Brussels at the end of September and featured high level speakers and experts. The event proved to be an ideal platform for discussing a number of topics of relevance to all the stakeholders in the healthcare system. The “Conflicts of Interest” session was […]